or
forgot password

    • cancer clinical trials in huntsville, AL

    • A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
    Ctr for Pain Management and Rehabilitation
    Huntsville, Alabama 35801
    HIV Infections, Cancer, Pain
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Huntsville Hospital System
    Huntsville, Alabama 35801
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Lung Cancer
    Talc in Treating Patients With Malignant Pleural Effusion
    Huntsville Hospital System
    Huntsville, Alabama 35801
    Metastatic Cancer
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Huntsville Hospital System
    Huntsville, Alabama 35801
    Breast Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Metastatic Cancer
    Marimastat in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Lung Cancer
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    Huntsville Hospital System
    Huntsville, Alabama 35801
    Breast Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Brain and Central Nervous System Tumors
    Eflornithine in Treating Patients With Bladder Cancer
    Intouch Research
    Huntsville, Alabama 35801
    Bladder Cancer
    Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Diarrhea, Radiation Enteritis
    Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Anemia, Head and Neck Cancer
    Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Head and Neck Cancer
    Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Colorectal Cancer
    Paclitaxel With or Without Gemcitabine in Treating Women With Advanced Breast Cancer
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Breast Cancer
    Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Lung Cancer
    Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Head and Neck Cancer, Oral Complications, Radiation Toxicity
    Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Stage III Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage IVA Adult Soft Tissue Sarcoma, Stage IIB Adult Soft Tissue Sarcoma, Stage IIC Adult Soft Tissue Sarcoma
    Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
    Huntsville Hospital System

    Trial Locations
    Huntsville Hospital System
    Comprehensive Cancer Institute of Huntsville
    Sarcoma
    Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Prostate Cancer
    A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
    Private Practice
    Huntsville, Alabama 35801
    Prostatic Intraepithelial Neoplasia
    Clinical Trial in Males With BPH (Enlarged Prostate)
    Medical Affiliated Research Center, Inc
    Huntsville, Alabama 35801
    Urinary Retention, Prostatic Hyperplasia, Benign Prostatic Hypertrophy
    Melatonin and Radiation Therapy in Treating Patients With Brain Metastases
    Comprehensive Cancer Institute of Huntsville
    Huntsville, Alabama 35801
    Metastatic Cancer, Radiation Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
    A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.
    "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"
    Huntsville, Alabama
    Colorectal Cancer
    Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Carcinoma of Unknown Primary
    Prialt (Ziconotide) In Severe Chronic Pain
    Tennesee Valley Pain Consultants - Center For Pain Management
    Huntsville, Alabama 35801
    Pain
    Clinical Trial for Ovarian Cancer (OvaRex®)
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Ovarian Cancer
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Medical Affiliated Research Center
    Huntsville, Alabama 35801
    Prostatic Neoplasms
    Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
    Comprehensive Cancer Institute
    Huntsville, Alabama 35801
    Pancreatic Cancer
    The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
    Medical Affiliated Research Center
    Huntsville, Alabama 35801
    Prostate Cancer
    Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
    Alabama Pain Center

    Trial Locations
    Alabama Pain Center
    Center for Pain Management
    Pain
    A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)
    Medical Affiliated Research Center, Inc.

    Trial Locations
    Medical Affiliated Research Center, Inc.
    Ruth A. Yates, MD
    Psoriasis